SCOPUS 정보 검색 플랫폼

Hepatology International

Volumn 4, Issue 4, 2010, Pages 723-731

Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C

(3) Pattullo, Venessa a,b Heathcote, E Jenny a Wong, David K H a

a TORONTO WESTERN HOSPITAL (Canada)

b UNIVERSITY OF SYDNEY (Australia)

Author keywords

Asian; Body mass index; Chronic hepatitis C; Diabetes; Obesity; Sustained virological response; Weight

Indexed keywords

PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; ARTICLE; ASIAN; BODY MASS; CAMBODIA; CAUCASIAN; CHINA; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG RESPONSE; FEMALE; GENOTYPE; HEPATITIS C; HONG KONG; HUMAN; HUMAN TISSUE; KOREA; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MYANMAR; OBESITY; OUTCOME ASSESSMENT; PHILIPPINES; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOUTH ASIA; TAIWAN; TREATMENT DURATION; VIET NAM; VIRUS LOAD;

EID: 78649487476 PISSN: 19360533 EISSN: 19360541 Source Type: Journal
DOI: 10.1007/s12072-010-9207-1 Document Type: Article

Times cited : (12)

References (37)

1
- 0035934568
- Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
- DOI 10.1016/S0140-6736(01)06102-5
- MP Manns JG McHutchison SC Gordon VK Rustgi M Shiffman R Reindollar ZD Goodman K Koury M Ling JK Albrecht 2001 Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 958 965 1:CAS:528: DC%2BD3MXntF2qtb8%3D 10.1016/S0140-6736(01)06102-5 11583749 (Pubitemid 32913521)
- (2001) Lancet , vol.358 , Issue.9286 , pp. 958-965
- Manns, M.P.¹ McHutchison, J.G.² Gordon, S.C.³ Rustgi, V.K.⁴ Shiffman, M.⁵ Reindollar, R.⁶ Goodman, Z.D.⁷ Koury, K.⁸ Ling, M.-H.⁹ Albrecht, J.K.¹⁰

2
- 0037179698
- Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
- 1:CAS:528:DC%2BD38Xnt12rtb0%3D 10.1056/NEJMoa020047 12324553
- MW Fried ML Shiffman KR Reddy C Smith G Marinos FL Goncales Jr D Haussinger M Diago G Carosi D Dhumeaux A Craxi A Lin J Hoffman J Yu 2002 Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 975 982 1:CAS:528:DC%2BD38Xnt12rtb0%3D 10.1056/NEJMoa020047 12324553
- (2002) N Engl J Med , vol.347 , pp. 975-982
- Fried, M.W.¹ Shiffman, M.L.² Reddy, K.R.³ Smith, C.⁴ Marinos, G.⁵ Goncales Jr., F.L.⁶ Haussinger, D.⁷ Diago, M.⁸ Carosi, G.⁹ Dhumeaux, D.¹⁰ Craxi, A.¹¹ Lin, A.¹² Hoffman, J.¹³ Yu, J.¹⁴

3
- 1542378867
- Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose
- 1:CAS:528:DC%2BD2cXitlOktrg%3D 14996676
- SJ Hadziyannis H Sette Jr TR Morgan V Balan M Diago P Marcellin G Ramadori H Bodenheimer Jr D Bernstein M Rizzetto S Zeuzem PJ Pockros A Lin AM Ackrill 2004 Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose Ann Intern Med 140 346 355 1:CAS:528:DC%2BD2cXitlOktrg%3D 14996676
- (2004) Ann Intern Med , vol.140 , pp. 346-355
- Hadziyannis, S.J.¹ Sette Jr., H.² Morgan, T.R.³ Balan, V.⁴ Diago, M.⁵ Marcellin, P.⁶ Ramadori, G.⁷ Bodenheimer Jr., H.⁸ Bernstein, D.⁹ Rizzetto, M.¹⁰ Zeuzem, S.¹¹ Pockros, P.J.¹² Lin, A.¹³ Ackrill, A.M.¹⁴

4
- 15744381704
- Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
- DOI 10.1053/j.gastro.2004.12.049
- M Romero-Gomez M Del Mar Viloria RJ Andrade J Salmeron M Diago CM Fernandez-Rodriguez R Corpas M Cruz L Grande L Vazquez P Munoz-De-Rueda P Lopez-Serrano A Gila ML Gutierrez C Perez A Ruiz-Extremera E Suarez J Castillo 2005 Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients Gastroenterology 128 636 641 1:CAS:528:DC%2BD2MXivFWntL8%3D 10.1053/j.gastro.2004.12.049 15765399 (Pubitemid 40585366)
- (2005) Gastroenterology , vol.128 , Issue.3 , pp. 636-641
- Romero-Gomez, M.¹ Del Mar Viloria, M.² Andrade, R.J.³ Salmeron, J.⁴ Diago, M.⁵ Fernandez-Rodriguez, C.M.⁶ Corpas, R.⁷ Cruz, M.⁸ Grande, L.⁹ Vazquez, L.¹⁰ Munoz-De-Rueda, P.¹¹ Lopez-Serrano, P.¹² Gila, A.¹³ Gutierrez, M.L.¹⁴ Perez, C.¹⁵ Ruiz-Extremera, A.¹⁶ Suarez, E.¹⁷ Castillo, J.¹⁸

5
- 33846463006
- Race, insulin resistance and hepatic steatosis in chronic hepatitis C
- DOI 10.1002/hep.21455
- HS Conjeevaram DE Kleiner JE Everhart JH Hoofnagle S Zacks NH Afdhal AS Wahed 2007 Race, insulin resistance and hepatic steatosis in chronic hepatitis C Hepatology 45 80 87 1:CAS:528:DC%2BD2sXht1arsbo%3D 10.1002/hep.21455 17187406 (Pubitemid 46144367)
- (2007) Hepatology , vol.45 , Issue.1 , pp. 80-87
- Conjeevaram, H.S.¹ Kleiner, D.E.² Everhart, J.E.³ Hoofnagle, J.H.⁴ Zacks, S.⁵ Afdhal, N.H.⁶ Wahed, A.S.⁷

6
- 19044361835
- Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection
- DOI 10.1053/j.gastro.2005.01.059, PII S0016508505003999
- L Chen I Borozan J Feld J Sun LL Tannis C Coltescu J Heathcote AM Edwards ID McGilvray 2005 Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection Gastroenterology 128 1437 1444 1:CAS:528:DC%2BD2MXlt1CisL0%3D 10.1053/j.gastro.2005.01.059 15887125 (Pubitemid 40712193)
- (2005) Gastroenterology , vol.128 , Issue.5 , pp. 1437-1444
- Chen, L.¹ Borozan, I.² Feld, J.³ Sun, J.⁴ Tannis, L.-L.⁵ Coltescu, C.⁶ Heathcote, J.⁷ Edwards, A.M.⁸ McGilvray, I.D.⁹

7
- 70349292099
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- 1:CAS:528:DC%2BD1MXpvFCrtbw%3D 10.1038/nature08309 19684573
- D Ge J Fellay AJ Thompson JS Simon KV Shianna TJ Urban EL Heinzen P Qiu AH Bertelsen AJ Muir M Sulkowski JG McHutchison DB Goldstein 2009 Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 399 401 1:CAS:528:DC%2BD1MXpvFCrtbw%3D 10.1038/nature08309 19684573
- (2009) Nature , vol.461 , pp. 399-401
- Ge, D.¹ Fellay, J.² Thompson, A.J.³ Simon, J.S.⁴ Shianna, K.V.⁵ Urban, T.J.⁶ Heinzen, E.L.⁷ Qiu, P.⁸ Bertelsen, A.H.⁹ Muir, A.J.¹⁰ Sulkowski, M.¹¹ McHutchison, J.G.¹² Goldstein, D.B.¹³

8
- 70349548852
- IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy
- 1:CAS:528:DC%2BD1MXhtFaju7%2FM 10.1038/ng.447 19749758
- V Suppiah M Moldovan G Ahlenstiel T Berg M Weltman ML Abate M Bassendine U Spengler GJ Dore E Powell S Riordan D Sheridan A Smedile V Fragomeli T Muller M Bahlo GJ Stewart DR Booth J George 2009 IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 1100 1104 1:CAS:528:DC%2BD1MXhtFaju7%2FM 10.1038/ng.447 19749758
- (2009) Nat Genet , vol.41 , pp. 1100-1104
- Suppiah, V.¹ Moldovan, M.² Ahlenstiel, G.³ Berg, T.⁴ Weltman, M.⁵ Abate, M.L.⁶ Bassendine, M.⁷ Spengler, U.⁸ Dore, G.J.⁹ Powell, E.¹⁰ Riordan, S.¹¹ Sheridan, D.¹² Smedile, A.¹³ Fragomeli, V.¹⁴ Muller, T.¹⁵ Bahlo, M.¹⁶ Stewart, G.J.¹⁷ Booth, D.R.¹⁸ George, J.¹⁹

9
- 70349533037
- Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
- 1:CAS:528:DC%2BD1MXhtFaju73K 10.1038/ng.449 19749757
- Y Tanaka N Nishida M Sugiyama M Kurosaki K Matsuura N Sakamoto M Nakagawa M Korenaga K Hino S Hige Y Ito E Mita E Tanaka S Mochida Y Murawaki M Honda A Sakai Y Hiasa S Nishiguchi A Koike I Sakaida M Imamura K Ito K Yano N Masaki F Sugauchi N Izumi K Tokunaga M Mizokami 2009 Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 1105 1109 1:CAS:528:DC%2BD1MXhtFaju73K 10.1038/ng.449 19749757
- (2009) Nat Genet , vol.41 , pp. 1105-1109
- Tanaka, Y.¹ Nishida, N.² Sugiyama, M.³ Kurosaki, M.⁴ Matsuura, K.⁵ Sakamoto, N.⁶ Nakagawa, M.⁷ Korenaga, M.⁸ Hino, K.⁹ Hige, S.¹⁰ Ito, Y.¹¹ Mita, E.¹² Tanaka, E.¹³ Mochida, S.¹⁴ Murawaki, Y.¹⁵ Honda, M.¹⁶ Sakai, A.¹⁷ Hiasa, Y.¹⁸ Nishiguchi, S.¹⁹ Koike, A.²⁰ more..

10
- 36349022057
- Impact of weight-based ribavirin with peginterferon alfa-2b in African Americans with hepatitis C virus genotype 1
- DOI 10.1002/hep.21670
- IM Jacobson RS Brown Jr J McCone M Black C Albert MS Dragutsky FA Siddiqui T Hargrave PY Kwo L Lambiase GW Galler V Araya B Freilich J Harvey LH Griffel CA Brass 2007 Impact of weight-based ribavirin with peginterferon alfa-2b in African Americans with hepatitis C virus genotype 1 Hepatology 46 982 990 1:CAS:528:DC%2BD2sXht1aksrzF 10.1002/hep.21670 17894323 (Pubitemid 350144762)
- (2007) Hepatology , vol.46 , Issue.4 , pp. 982-990
- Jacobson, I.M.¹ Brown Jr., R.S.² McCone, J.³ Black, M.⁴ Albert, C.⁵ Dragutsky, M.S.⁶ Siddiqui, F.A.⁷ Hargrave, T.⁸ Kwo, P.Y.⁹ Lambiase, L.¹⁰ Galler, G.W.¹¹ Araya, V.¹² Freilich, B.¹³ Harvey, J.¹⁴ Griffel, L.H.¹⁵ Brass, C.A.¹⁶

11
- 3843074028
- Differences in treatment outcome for hepatitis C among ethnic groups
- 1:CAS:528:DC%2BD2cXmtVWitro%3D 10.1016/j.amjmed.2004.02.043 15276594
- MJ Hepburn LM Hepburn NS Cantu MG Lapeer EJ Lawitz 2004 Differences in treatment outcome for hepatitis C among ethnic groups Am J Med 117 163 168 1:CAS:528:DC%2BD2cXmtVWitro%3D 10.1016/j.amjmed.2004.02.043 15276594
- (2004) Am J Med , vol.117 , pp. 163-168
- Hepburn, M.J.¹ Hepburn, L.M.² Cantu, N.S.³ Lapeer, M.G.⁴ Lawitz, E.J.⁵

12
- 37649018860
- Inferior response of Asian vs non-Asian hepatitis C genotype 3 infection to combination antiviral therapy
- 1:STN:280:DC%2BD1c%2Fit1ahtQ%3D%3D 18184194
- DA Freshwater K O'Donnell DJ Mutimer 2008 Inferior response of Asian vs non-Asian hepatitis C genotype 3 infection to combination antiviral therapy J Viral Hepat 15 115 119 1:STN:280:DC%2BD1c%2Fit1ahtQ%3D%3D 18184194
- (2008) J Viral Hepat , vol.15 , pp. 115-119
- Freshwater, D.A.¹ O'Donnell, K.² Mutimer, D.J.³

13
- 46249114151
- Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial
- DOI 10.1002/hep.22319
- ML Yu CY Dai JF Huang CF Chiu YH Yang NJ Hou LP Lee MY Hsieh ZY Lin SC Chen LY Wang WY Chang WL Chuang 2008 Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial Hepatology 47 1884 1893 1:CAS:528:DC%2BD1cXotVagtro%3D 10.1002/hep.22319 18508296 (Pubitemid 351945556)
- (2008) Hepatology , vol.47 , Issue.6 , pp. 1884-1893
- Yu, M.-L.¹ Dai, C.-Y.² Huang, J.-F.³ Chiu, C.-F.⁴ Yang, Y.-H.C.⁵ Hou, N.-J.⁶ Lee, L.-P.⁷ Hsieh, M.-Y.⁸ Lin, Z.-Y.⁹ Chen, S.-C.¹⁰ Hsieh, M.-Y.¹¹ Wang, L.-Y.¹² Chang, W.-Y.¹³ Chuang, W.-L.¹⁴

14
- 34147207791
- A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C
- DOI 10.1136/gut.2006.102558
- ML Yu CY Dai JF Huang NJ Hou LP Lee MY Hsieh CF Chiu ZY Lin SC Chen LY Wang WY Chang WL Chuang 2007 A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C Gut 56 553 559 1:CAS:528:DC%2BD2sXks1Giu7g%3D 10.1136/gut.2006.102558 16956917 (Pubitemid 46580512)
- (2007) Gut , vol.56 , Issue.4 , pp. 553-559
- Yu, M.-L.¹ Dai, C.-Y.² Huang, J.-F.³ Hou, N.-J.⁴ Lee, L.-P.⁵ Hsieh, M.-Y.⁶ Chiu, C.-F.⁷ Lin, Z.-Y.⁸ Chen, S.-C.⁹ Hsieh, M.-Y.¹⁰ Wang, L.-Y.¹¹ Chang, W.-Y.¹² Chuang, W.-L.¹³

15
- 34848862552
- Impact of Asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C
- DOI 10.1111/j.1572-0241.2007.01431.x
- S Missiha J Heathcote T Arenovich K Khan 2007 Impact of Asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C Am J Gastroenterol 102 2181 2188 1:CAS:528: DC%2BD2sXht12rs7%2FN 10.1111/j.1572-0241.2007.01431.x 17640318 (Pubitemid 47493845)
- (2007) American Journal of Gastroenterology , vol.102 , Issue.10 , pp. 2181-2188
- Missiha, S.¹ Heathcote, J.² Arenovich, T.³ Khan, K.⁴ Anderson, F.⁵ Bailey, R.⁶ Bain, V.⁷ Deschenes, M.⁸ Elkashab, M.⁹ Feinman, S.V.¹⁰ Heathcote, E.J.¹¹ Hilzenrat, N.¹² Kaita, K.¹³ Lee, S.¹⁴ Marotta, P.¹⁵ Peltekian, K.¹⁶ Scully, L.¹⁷ Sherman, M.¹⁸ Willems, B.¹⁹ Witt-Sullivan, H.²⁰ Worobetz, L.²¹ Yoshida, E.²² more..

16
- 0043037223
- High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C
- DOI 10.1053/jhep.2003.50350
- BL Bressler M Guindi G Tomlinson J Heathcote 2003 High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C Hepatology 38 639 644 1:CAS:528:DC%2BD3sXnvVKjt70%3D 10.1053/jhep.2003.50350 12939590 (Pubitemid 37052150)
- (2003) Hepatology , vol.38 , Issue.3 , pp. 639-644
- Bressler, B.L.¹ Guindi, M.² Tomlinson, G.³ Heathcote, J.⁴

17
- 33846246344
- Impact of Ribavirin Dose Reductions in Hepatitis C Virus Genotype 1 Patients Completing Peginterferon Alfa-2a/Ribavirin Treatment
- DOI 10.1016/j.cgh.2006.10.008, PII S1542356506010469
- KR Reddy ML Shiffman TR Morgan S Zeuzem S Hadziyannis FM Hamzeh TL Wright M Fried 2007 Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment Clin Gastroenterol Hepatol 5 124 129 1:CAS:528:DC%2BD2sXitVCmsbY%3D 10.1016/j.cgh.2006.10.008 17196435 (Pubitemid 46096836)
- (2007) Clinical Gastroenterology and Hepatology , vol.5 , Issue.1 , pp. 124-129
- Reddy, K.R.¹ Shiffman, M.L.² Morgan, T.R.³ Zeuzem, S.⁴ Hadziyannis, S.⁵ Hamzeh, F.M.⁶ Wright, T.L.⁷ Fried, M.⁸

18
- 48749099989
- Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response
- 1:CAS:528:DC%2BD1cXhtVCqsL%2FJ 10.1053/j.gastro.2008.04.015 18503773
- P Ferenci H Laferl TM Scherzer M Gschwantler A Maieron H Brunner R Stauber M Bischof B Bauer C Datz K Loschenberger E Formann K Staufer P Steindl-Munda 2008 Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response Gastroenterology 135 451 458 1:CAS:528:DC%2BD1cXhtVCqsL%2FJ 10.1053/j.gastro.2008.04.015 18503773
- (2008) Gastroenterology , vol.135 , pp. 451-458
- Ferenci, P.¹ Laferl, H.² Scherzer, T.M.³ Gschwantler, M.⁴ Maieron, A.⁵ Brunner, H.⁶ Stauber, R.⁷ Bischof, M.⁸ Bauer, B.⁹ Datz, C.¹⁰ Loschenberger, K.¹¹ Formann, E.¹² Staufer, K.¹³ Steindl-Munda, P.¹⁴

19
- 0037898228
- Human leukocyte antigen class I and II alleles and response to interferon-α treatment, in Taiwanese patients with chronic hepatitis C virus infection
- DOI 10.1086/375554
- ML Yu CY Dai SC Chen CC Chiu LP Lee ZY Lin MY Hsieh LY Wang WL Chuang WY Chang 2003 Human leukocyte antigen class I and II alleles and response to interferon-alpha treatment, in Taiwanese patients with chronic hepatitis C virus infection J Infect Dis 188 62 65 1:CAS:528:DC%2BD3sXmtFGhtLg%3D 10.1086/375554 12825172 (Pubitemid 36829743)
- (2003) Journal of Infectious Diseases , vol.188 , Issue.1 , pp. 62-65
- Yu, M.-L.¹ Dai, C.-Y.² Chen, S.-C.³ Chiu, C.-C.⁴ Lee, L.-P.⁵ Lin, Z.-Y.⁶ Hsieh, M.-Y.⁷ Wang, L.-Y.⁸ Chuang, W.-L.⁹ Chang, W.-Y.¹⁰

20
- 29744442515
- Tumor necrosis factor-α promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection
- DOI 10.1086/498244
- CY Dai WL Chuang WY Chang SC Chen LP Lee MY Hsieh NJ Hou ZY Lin JF Huang LY Wang ML Yu 2006 Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection J Infect Dis 193 98 101 1:CAS:528:DC%2BD28Xks12gug%3D%3D 10.1086/498244 16323137 (Pubitemid 43032504)
- (2006) Journal of Infectious Diseases , vol.193 , Issue.1 , pp. 98-101
- Dai, C.-Y.¹ Chuang, W.-L.² Chang, W.-Y.³ Chen, S.-C.⁴ Lee, L.-P.⁵ Hsieh, M.-Y.⁶ Hou, N.-J.⁷ Lin, Z.-Y.⁸ Huang, J.-F.⁹ Hsieh, M.-Y.¹⁰ Wang, L.-Y.¹¹ Yu, M.-L.¹²

21
- 41149095973
- Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C
- DOI 10.1136/gut.2007.129478
- M Persico M Capasso R Russo E Persico L Croce C Tiribelli A Iolascon 2008 Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C Gut 57 507 515 1:CAS:528: DC%2BD1cXltVKntbg%3D 10.1136/gut.2007.129478 17881539 (Pubitemid 351442535)
- (2008) Gut , vol.57 , Issue.4 , pp. 507-515
- Persico, M.¹ Capasso, M.² Russo, R.³ Persico, E.⁴ Croce, L.⁵ Tiribelli, C.⁶ Iolascon, A.⁷

22
- 33645114359
- Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1
- 1:CAS:528:DC%2BD28XjslWls7g%3D 10.1136/gut.2005.069674 16299039
- MJ Walsh JR Jonsson MM Richardson GM Lipka DM Purdie AD Clouston EE Powell 2006 Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1 Gut 55 529 535 1:CAS:528:DC%2BD28XjslWls7g%3D 10.1136/gut.2005.069674 16299039
- (2006) Gut , vol.55 , pp. 529-535
- Walsh, M.J.¹ Jonsson, J.R.² Richardson, M.M.³ Lipka, G.M.⁴ Purdie, D.M.⁵ Clouston, A.D.⁶ Powell, E.E.⁷

23
- 78649464609
- Obesity: Preventing and managing a global epidemic. Report on a WHO Consultation in Obesity, Geneva 3-5 June, 1997. WHO/NUT/NCD/98.1
- WHO Geneva: World Health Organization
- WHO. Obesity: preventing and managing a global epidemic. Report on a WHO Consultation in Obesity, Geneva 3-5 June, 1997. WHO/NUT/NCD/98.1. Technical Report Series Number 894. Volume WHO/NUT/NCD/98.1. Technical Report Series Number 894. Geneva: World Health Organization; 2000
- (2000) Technical Report Series Number 894. Volume WHO/NUT/NCD/98.1. Technical Report Series Number 894

24
- 85066456886
- Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
- WHO Expert Consultation
- WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163
- (2004) Lancet , vol.363 , pp. 157-163

25
- 36949040347
- Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3
- 1:STN:280:DC%2BD2sjltFWntA%3D%3D 18088245
- J Powis KM Peltekian SS Lee M Sherman VG Bain C Cooper M Krajden M Deschenes RF Balshaw EJ Heathcote EM Yoshida 2008 Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3 J Viral Hepat 15 52 57 1:STN:280:DC%2BD2sjltFWntA%3D%3D 18088245
- (2008) J Viral Hepat , vol.15 , pp. 52-57
- Powis, J.¹ Peltekian, K.M.² Lee, S.S.³ Sherman, M.⁴ Bain, V.G.⁵ Cooper, C.⁶ Krajden, M.⁷ Deschenes, M.⁸ Balshaw, R.F.⁹ Heathcote, E.J.¹⁰ Yoshida, E.M.¹¹

26
- 0034897720
- Changing prevalence of hepatitis C virus genotypes: Molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a Tertiary Referral Center in Taiwan
- DOI 10.1002/jmv.2001
- ML Yu WL Chuang SC Chen CY Dai C Hou JH Wang SN Lu JF Huang ZY Lin MY Hsieh JF Tsai LY Wang WY Chang 2001 Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan J Med Virol 65 58 65 1:STN:280:DC%2BD3MvlvVGrsA%3D%3D 10.1002/jmv.2001 11505444 (Pubitemid 32727007)
- (2001) Journal of Medical Virology , vol.65 , Issue.1 , pp. 58-65
- Candotti, D.¹ Mundy, C.² Kadewele, G.³ Nkhoma, W.⁴ Bates, I.⁵ Allain, J.-P.⁶

27
- 37249068019
- Virological response in patients with hepatitis C virus genotype 1b and a high viral load: Impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors
- 1:CAS:528:DC%2BD1cXhvVCmsLs%3D 10.2165/00044011-200828010-00002 18081356
- G Yamada S Iino T Okuno M Omata K Kiyosawa H Kumada N Hayashi T Sakai 2008 Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors Clin Drug Investig 28 9 16 1:CAS:528: DC%2BD1cXhvVCmsLs%3D 10.2165/00044011-200828010-00002 18081356
- (2008) Clin Drug Investig , vol.28 , pp. 9-16
- Yamada, G.¹ Iino, S.² Okuno, T.³ Omata, M.⁴ Kiyosawa, K.⁵ Kumada, H.⁶ Hayashi, N.⁷ Sakai, T.⁸

28
- 51749084677
- Chronic hepatitis C virus genotype 6 infection: Response to pegylated interferon and ribavirin
- 1:CAS:528:DC%2BD1cXhtFygs7rF 10.1086/591252 18657036
- J Fung CL Lai I Hung J Young C Cheng D Wong MF Yuen 2008 Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin J Infect Dis 198 808 812 1:CAS:528:DC%2BD1cXhtFygs7rF 10.1086/591252 18657036
- (2008) J Infect Dis , vol.198 , pp. 808-812
- Fung, J.¹ Lai, C.L.² Hung, I.³ Young, J.⁴ Cheng, C.⁵ Wong, D.⁶ Yuen, M.F.⁷

29
- 33750944590
- Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5′ untranslated regions
- DOI 10.1128/JCM.01122-06
- S Noppornpanth E Sablon K De Nys XL Truong J Brouwer M Van Brussel SL Smits Y Poovorawan AD Osterhaus BL Haagmans 2006 Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5′ untranslated regions J Clin Microbiol 44 3969 3974 1:CAS:528:DC%2BD28XhtlSnu7vO 10.1128/JCM.01122-06 16957039 (Pubitemid 44737237)
- (2006) Journal of Clinical Microbiology , vol.44 , Issue.11 , pp. 3969-3974
- Noppornpanth, S.¹ Sablon, E.² De Nys, K.³ Lien, T.X.⁴ Brouwer, J.⁵ Van Brussel, M.⁶ Smits, S.L.⁷ Poovorawan, Y.⁸ Osterhaus, A.D.M.E.⁹ Haagmans, B.L.¹⁰

30
- 77951976635
- Similar treatment response to peginterferon and ribavirin in Asian and Caucasian patients with chronic hepatitis C
- Vutien P, Nguyen NH, Trinh HN, Li J, Garcia RT, Garcia G, Nguyen KK, Nguyen HA, Levitt BS, Keeffe EB, Nguyen MH. Similar treatment response to peginterferon and ribavirin in Asian and Caucasian patients with chronic hepatitis C. Am J Gastroenterol 2010;105:1110-1115
- (2010) Am J Gastroenterol , vol.105 , pp. 1110-1115
- Vutien, P.¹ Nguyen, N.H.² Trinh, H.N.³ Li, J.⁴ Garcia, R.T.⁵ Garcia, G.⁶ Nguyen, K.K.⁷ Nguyen, H.A.⁸ Levitt, B.S.⁹ Keeffe, E.B.¹⁰ Nguyen, M.H.¹¹

31
- 1042280195
- Type 2 diabetes prevalence in Asian Americans: Results of a national health survey
- DOI 10.2337/diacare.27.1.66
- MJ McNeely EJ Boyko 2004 Type 2 diabetes prevalence in Asian Americans: results of a national health survey Diabetes Care 27 66 69 10.2337/diacare.27.1. 66 14693968 (Pubitemid 38196711)
- (2004) Diabetes Care , vol.27 , Issue.1 , pp. 66-69
- McNeely, M.J.¹ Boyko, E.J.²

32
- 68249154875
- Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection
- 1:CAS:528:DC%2BD1MXps1Kjuro%3D 10.1056/NEJMoa0808010 19625712
- JG McHutchison EJ Lawitz ML Shiffman AJ Muir GW Galler J McCone LM Nyberg WM Lee RH Ghalib ER Schiff JS Galati BR Bacon MN Davis P Mukhopadhyay K Koury S Noviello LD Pedicone CA Brass JK Albrecht MS Sulkowski 2009 Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection N Engl J Med 361 580 593 1:CAS:528:DC%2BD1MXps1Kjuro%3D 10.1056/NEJMoa0808010 19625712
- (2009) N Engl J Med , vol.361 , pp. 580-593
- McHutchison, J.G.¹ Lawitz, E.J.² Shiffman, M.L.³ Muir, A.J.⁴ Galler, G.W.⁵ McCone, J.⁶ Nyberg, L.M.⁷ Lee, W.M.⁸ Ghalib, R.H.⁹ Schiff, E.R.¹⁰ Galati, J.S.¹¹ Bacon, B.R.¹² Davis, M.N.¹³ Mukhopadhyay, P.¹⁴ Koury, K.¹⁵ Noviello, S.¹⁶ Pedicone, L.D.¹⁷ Brass, C.A.¹⁸ Albrecht, J.K.¹⁹ Sulkowski, M.S.²⁰ more..

33
- 72249083270
- Randomized study of peginterferon-alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C
- Rumi MG, Aghemo A, Prati GM, D'Ambrosio R, Donato MF, Soffredini R, Del Ninno E, Russo A, Colombo M. Randomized study of peginterferon-alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C. Gastroenterology 2010;138:108-115
- (2010) Gastroenterology , vol.138 , pp. 108-115
- Rumi, M.G.¹ Aghemo, A.² Prati, G.M.³ D'Ambrosio, R.⁴ Donato, M.F.⁵ Soffredini, R.⁶ Del Ninno, E.⁷ Russo, A.⁸ Colombo, M.⁹

34
- 72249094116
- Peginterferon alfa-2a plus ribavirin is more effective than peginterferon alfa-2b plus ribavirin for treating chronic hepatitis C virus infection
- Ascione A, De Luca M, Tartaglione MT, Lampasi F, Di Costanzo GG, Lanza AG, Picciotto FP, Marino-Marsilia G, Fontanella L, Leandro G. Peginterferon alfa-2a plus ribavirin is more effective than peginterferon alfa-2b plus ribavirin for treating chronic hepatitis C virus infection. Gastroenterology 2010;138:116-122
- (2010) Gastroenterology , vol.138 , pp. 116-122
- Ascione, A.¹ De Luca, M.² Tartaglione, M.T.³ Lampasi, F.⁴ Di Costanzo, G.G.⁵ Lanza, A.G.⁶ Picciotto, F.P.⁷ Marino-Marsilia, G.⁸ Fontanella, L.⁹ Leandro, G.¹⁰

35
- 77950622393
- Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials
- Awad T, Thorlund K, Hauser G, Stimac D, Mabrouk M, Gluud C. Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized trials. Hepatology 2010;51:1176-1184
- (2010) Hepatology , vol.51 , pp. 1176-1184
- Awad, T.¹ Thorlund, K.² Hauser, G.³ Stimac, D.⁴ Mabrouk, M.⁵ Gluud, C.⁶

36
- 84984585908
- Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy
- 1:CAS:528:DC%2BD1MXktVerurg%3D 19320236
- CS Hsu CH Liu CJ Liu CL Chen MY Lai PJ Chen DS Chen JH Kao 2009 Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy Antivir Ther 14 45 54 1:CAS:528:DC%2BD1MXktVerurg%3D 19320236
- (2009) Antivir Ther , vol.14 , pp. 45-54
- Hsu, C.S.¹ Liu, C.H.² Liu, C.J.³ Chen, C.L.⁴ Lai, M.Y.⁵ Chen, P.J.⁶ Chen, D.S.⁷ Kao, J.H.⁸

37
- 78649249565
- Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C
- doi:10.1111/j.1365-2893.2010.01248.x
- Pattullo V, Ravindran NC, Mazzulli T, Wong DK, Heathcote EJ. Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C. J Viral Hepat 2010. doi: 10.1111/j.1365-2893. 2010.01248.x
- (2010) J Viral Hepat
- Pattullo, V.¹ Ravindran, N.C.² Mazzulli, T.³ Wong, D.K.⁴ Heathcote, E.J.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.